Seema Patrikar1, D R Basannar2, V K Bhatti3, A Kotwal4, R M Gupta5, R S Grewal6. 1. Lecturer in Statistics and Demography, Department of Community Medicine, Armed Forces Medical College, Pune 40, India. 2. Scientist 'E', Department of Community Medicine, Armed Forces Medical College, Pune 40, India. 3. Col Health, HQ Northern Command, India. 4. Director AFMS (Medical Research), O/o DGAFMS, New Delhi, India. 5. Senior Advisor (Microbiology), Command Hospital (Northern Command), C/o 99 APO, India. 6. Dy DGAFMS (Prov), O/o DGAFMS, New Delhi, India.
Abstract
BACKGROUND: The progressive decline in the CD4 count in HIV patients leads to a more general decline in immune functioning. The study has been carried out to determine the decline in CD4 count in HIV patients. METHODS: The study was conducted in a medical college hospital at Maharashtra. The information on baseline CD4 count was gathered from positive patient records registered in the central disease registry. The baseline CD4 count was the first count of CD4 obtained when the patient is diagnosed as HIV positive and further two subsequent readings. The time from baseline (t1) till the last CD4 count (t2) was divided into the different quartiles and the median decline in CD4 count in each quartile was determined. As the time between the two CD4 count measurements was not uniform the rate of change in CD4 was measured with respect to time as [X (t2) - X (t1)/(t2 - t1)]. Correlation was assessed using correlation coefficient. RESULTS: As the CD4 counts were following skewed distribution, the normality was achieved by cuberoot transformation. The overall rate of decline in CD4 count was estimated to be 35 cells/μL per year with 95% confidence interval (CI) as (17.01, 85.04). The correlation coefficient between decline in CD4 and the initial CD4 count in the four time quartiles was (r = -0.51; p = 0.001, r = -0.79; p = 0.000, r = -0.48; p = 0.015 and r = -0.80; p = 0.000) respectively. The median decline in the CD4 count in 0-6 months was 3 cells/μL, in (6-11) months was approximately 26 cells/μL, in (11-21.5) months was 30 cells/μL and in more than 21.5 months the median decline was 52 cells/μL. CONCLUSIONS: There was a progressive decline in the CD4 count following HIV infection. An understanding of the influence of decline in CD4 count in HIV patients not on ART is important for clinical management of HIV disease.
BACKGROUND: The progressive decline in the CD4 count in HIVpatients leads to a more general decline in immune functioning. The study has been carried out to determine the decline in CD4 count in HIVpatients. METHODS: The study was conducted in a medical college hospital at Maharashtra. The information on baseline CD4 count was gathered from positive patient records registered in the central disease registry. The baseline CD4 count was the first count of CD4 obtained when the patient is diagnosed as HIV positive and further two subsequent readings. The time from baseline (t1) till the last CD4 count (t2) was divided into the different quartiles and the median decline in CD4 count in each quartile was determined. As the time between the two CD4 count measurements was not uniform the rate of change in CD4 was measured with respect to time as [X (t2) - X (t1)/(t2 - t1)]. Correlation was assessed using correlation coefficient. RESULTS: As the CD4 counts were following skewed distribution, the normality was achieved by cuberoot transformation. The overall rate of decline in CD4 count was estimated to be 35 cells/μL per year with 95% confidence interval (CI) as (17.01, 85.04). The correlation coefficient between decline in CD4 and the initial CD4 count in the four time quartiles was (r = -0.51; p = 0.001, r = -0.79; p = 0.000, r = -0.48; p = 0.015 and r = -0.80; p = 0.000) respectively. The median decline in the CD4 count in 0-6 months was 3 cells/μL, in (6-11) months was approximately 26 cells/μL, in (11-21.5) months was 30 cells/μL and in more than 21.5 months the median decline was 52 cells/μL. CONCLUSIONS: There was a progressive decline in the CD4 count following HIV infection. An understanding of the influence of decline in CD4 count in HIVpatients not on ART is important for clinical management of HIV disease.
Entities:
Keywords:
Antiretroviral therapy (ART); CD4 count; Human immunodeficiency virus (HIV)
Authors: Anthony L Cunningham; Heather Donaghy; Andrew N Harman; Min Kim; Stuart G Turville Journal: Curr Opin Microbiol Date: 2010-07-02 Impact factor: 7.934
Authors: Thierry Buclin; Amalio Telenti; Rafael Perera; Chantal Csajka; Hansjakob Furrer; Jeffrey K Aronson; Paul P Glasziou Journal: PLoS One Date: 2011-04-08 Impact factor: 3.240
Authors: Jialun Zhou; Thira Sirisanthana; Sasisopin Kiertiburanakul; Yi-Ming A Chen; Ning Han; Poh Lian Lim; Nagalingeswaran Kumarasamy; Jun Yong Choi; Tuti Parwati Merati; Evy Yunihastuti; Shinichi Oka; Adeeba Kamarulzaman; Praphan Phanuphak; Christopher K C Lee; Patrick C K Li; Sanjay Pujari; Vanthanak Saphonn; Matthew G Law Journal: BMC Infect Dis Date: 2010-12-23 Impact factor: 3.090
Authors: Luuk Gras; Ronald B Geskus; Suzanne Jurriaans; Margreet Bakker; Ard van Sighem; Daniela Bezemer; Christophe Fraser; Jan M Prins; Ben Berkhout; Frank de Wolf Journal: PLoS One Date: 2013-05-27 Impact factor: 3.240
Authors: Soledad Colombe; Paul L A M Corstjens; Claudia J de Dood; Donald Miyaye; Ruth G Magawa; Julius Mngara; Samuel E Kalluvya; Lisette van Lieshout; Govert J van Dam; Jennifer A Downs Journal: Front Immunol Date: 2018-09-06 Impact factor: 7.561
Authors: Karan Patel; Alex Zhang; Michelle H Zhang; Sean Bunachita; Basil M Baccouche; Henna Hundal; Liseth K Lavado; Aakshi Agarwal; Preeti Malik; Urvish K Patel Journal: Cureus Date: 2021-05-02